References
PROGRESSION, EVENTS, ADVERSE EVENT, ADVERSE EVENT
Time to viral load clearance. Shown is a Kaplan–Meier plot with 95% Hall–Wellner bands of time to clearance of SARS-CoV-2 RNA by treatment. Quartiles are derived from Kaplan–Meier product limit estimates. SARS-CoV-2 viral dynamics. Shown in top panel ((Demographics and clinical characteristics at baseline.WHO Clinical Progression Scale. Shown is the WHO Clinical Progression Scale score by study day and change from baseline.LS-mean and Adverse events.E: number of events; N: number of subjects dosed with each treatment; n: number of subjects with the adverse event and particular category.